Evidence map›Paper›PMID 40869694›Full record

ArticleJournal of clinical medicine2025

Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG).

Ali Kalem, Tulay Kus, Savas Gokcek, Ilkay Tugba Unek, Taha Koray Sahin, Omer Dizdar, Muhammed Fatih Sagıroglu, Hatice Bolek, Yuksel Urun, Sendag Yaslıkaya and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Ali KalemDepartment of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey.ORCID 0009-0001-0937-0468
Tulay KusDepartment of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey.ORCID 0000-0001-5781-4820
Savas GokcekDepartment of Medical Oncology, School of Medicine, Dokuz Eylul University, Izmir 35220, Turkey.
Ilkay Tugba UnekDepartment of Medical Oncology, School of Medicine, Dokuz Eylul University, Izmir 35220, Turkey.ORCID 0000-0002-9124-6123
Taha Koray SahinDepartment of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06800, Turkey.ORCID 0000-0002-3590-0426
Omer DizdarDepartment of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06800, Turkey.
Muhammed Fatih SagırogluDepartment of Medical Oncology, Gaziantep City Hospital, Gaziantep 27100, Turkey.
Hatice BolekDepartment of Medical Oncology, School of Medicine, Ankara University, Ankara 06620, Turkey.ORCID 0000-0001-8659-7327
Yuksel UrunDepartment of Medical Oncology, School of Medicine, Ankara University, Ankara 06620, Turkey.
Sendag YaslıkayaDepartment of Medical Oncology, School of Medicine, Çukurova University, Adana 01330, Turkey.ORCID 0000-0001-5264-8405
Ertugrul BayramDepartment of Medical Oncology, School of Medicine, Çukurova University, Adana 01330, Turkey.
Nadiye SeverDepartment of Medical Oncology, School of Medicine, Marmara University, İstanbul 34854, Turkey.ORCID 0000-0001-7312-3827
Ibrahim Vedat BayoğluDepartment of Medical Oncology, School of Medicine, Marmara University, İstanbul 34854, Turkey.ORCID 0000-0002-0481-1084
Omer AcarDepartment of Medical Oncology, School of Medicine, Manisa Celal Bayar University, Manisa 45140, Turkey.
Atike Pınar ErdoganDepartment of Medical Oncology, School of Medicine, Manisa Celal Bayar University, Manisa 45140, Turkey.ORCID 0000-0003-4859-7574
Seray SarayDepartment of Medical Oncology, Ataturk Education and Research Hospital, Balıkesir 10100, Turkey.ORCID 0000-0001-5916-6265
Berkan KarabugaDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara 06200, Turkey.ORCID 0000-0001-5357-7610
Ulku Arslan YalcıntasDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara 06200, Turkey.
Safa Can EfilDepartment of Medical Oncology, School of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06690, Turkey.
Mehmet Ali Nahit SendurDepartment of Medical Oncology, School of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06690, Turkey.ORCID 0000-0001-7021-6139
Talat AykutDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey.ORCID 0000-0002-9614-0651
Murat ArazDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey.ORCID 0000-0002-4632-9501
Tugce Kubra GunesDepartment of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul 34764, Turkey.
Melike OzcelikDepartment of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul 34764, Turkey.
Mustafa SeyyarDepartment of Medical Oncology, Gaziantep City Hospital, Gaziantep 27100, Turkey.ORCID 0000-0002-4841-7994
Gokmen AktasGaziantep Medical Point Private Hospital, Gaziantep 27584, Turkey.
Suayib YalcınDepartment of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06800, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ampullary tumorsFOLFIRINOXgemcitabine-basedintestinal subtypemetastaticpancreaticobiliary subtype

Identifiers

PMID40869694
PMCPMC12387938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.